Market Cap | ₹30Cr |
ROE | -15.11% |
P/E Ratio(TTM) | -31.50 |
EPS(TTM) | -1.27 |
P/B Ratio | 4.85 |
Dividend Yield | 0.00% |
Industry P/E | 40.02 |
Book Value | 8.26 |
Debt to Equity | 0.15 |
Face Value | 10 |
Parent Organisation | Gujarat Terce Laboratories Limited |
Managing Director | Mr. Aalap Prajapati |
BSE Symbol | 524314 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 61.56 | ||
Ajanta Pharma | NA (0.00%) | 34.44 | ||
Gland Pharma | NA (0.00%) | 41.06 | ||
Eris Lifesciences | NA (0.00%) | 60.18 |